drugset / Trial / NCT03618082

GOAL-Directed ANalgesia (GOALDAN)

NCT03618082

RandomizedParallel-groupSingle-blindPrevention

Summary

The primary purpose of GOALDAN study is to demonstrate the superiority of a targeted perioperative analgesic strategy by the ANI over the usual practice on the incidence of immediate postoperative pain. The investigators hypothesized that a prophylactic administration of morphine in patients with risk of postoperative pain determined by the ANI at the end of the intervention would reduce the incidence of immediate postoperative pain and that the targeted analgesia to ANI and minimal alveolar concentration (MAC) of desflurane could improve the perioperative hemodynamic, and the postoperative becoming.

Timeline

Start
2019-06-06
Primary completion
2022-05-13
Completion
2022-08-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Desflurane Other / unclassified
Subject Morphine Other / unclassified 0.1 mg/kg Intravenous
Subject Morphine Other / unclassified 0.2 mg/kg Intravenous
Subject Remifentanil Small molecule

Indications

No indication recorded.